The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 23, 1997

Filed:

Nov. 27, 1991
Applicant:
Inventors:

Roberto Crea, Bulingame, CA (US);

Roy Hoi Pang, Medway, MA (US);

Hermann Oppermann, San Francisco, CA (US);

Peter C Keck, Millbury, MA (US);

Gabriel Alvarado-Urbina, Nepean, CA;

Gay-May Wu, Westboro, MA (US);

Charles M Cohen, Medway, MA (US);

Assignees:

Creative BioMolecules, Inc., Hopkinton, MA (US);

A. Menarini S.A.S., Firenzi, IT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N / ; C07K / ; A61K / ;
U.S. Cl.
CPC ...
435226 ; 435212 ; 435219 ; 435 697 ; 530300 ; 530324 ; 530350 ;
Abstract

Protein analogues of tissue plasminogen activator (tPA) are described. The analogues exhibit the proteolytic function of natural tPA and optionally fibrin binding activity, but are molecules, generally of lower molecular weight than natural tPA, designed for efficient expression in prokaryotic host cell systems. The analogues can comprise a catalytic fragment of tPA or a catalytic fragment of tPA linked to a polypeptide which stabilizes the catalytic fragment, provides for efficient expression of the fragment or confers a fibrin binding capability. Fibrin binding polypeptides can be a polypeptide fragments derived from tPA which embody the fibrin binding domain(s) of natural tPA or they can be an exogenous (non-tPA) polypeptides of eukaryotic or prokaryotic origin which exhibit fibrin binding affinity such as the antigen binding fragment of an antifibrin immunoglobulin or the B domain of protein A. Genetic constructs for expression of the analogues are also provided.


Find Patent Forward Citations

Loading…